← All organizations

Chengdu Olymvax Biopharmaceuticals Inc.

For profitWebsite ↗

Also known as: Chengdu Olymvax Biopharmaceuticals Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 16, 2019

Timeline

2000s

Jun 1, 2009
Chengdu Olymvax Biopharmaceuticals Inc.— Founded

Drugs by trial phase (4 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

haemophilus influenzae type b conjugate vaccine

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (4)

NCT03966040CollaboratorPhase 1May 16, 2019
NCT02804711CollaboratorPhase 1Sep 1, 2016
NCT02820883CollaboratorEarly Phase 1Jun 1, 2016
NCT02692859CollaboratorPhase 3Sep 1, 2013

Details

Founded: Chengdu, CN Jun 1, 2009
Last known activity: May 16, 2019